The recent disruptions in global supply have highlighted the value of securing essential medications like Ivermectin. Relying on overseas producers exposes countries to potential vulnerabilities, including delivery delays, expense fluctuations, and even trade concerns. Shifting towards domestic production of Ivermectin offers a multitude of benefit